Feature | MCTDa | Controls | Pvalue, MCTD vs. controls | MCTDb CVD+ | MCTD CVD- | Pvalue, MCTD/CVD+ vs. MCTD/CVD- |
---|---|---|---|---|---|---|
n | 50 | 38 | Â | 23 | 27 | Â |
Age at investigation (years) | 50.2 ± 10.0 | 50.4 ± 10.3 | 0.936 | 50.1 ± 10.7 | 50.2 ± 9.5 | 0.99 |
Disease duration (years) | 9.56 ± 6.8 (3 to 26) | - | - | 10.3 ± 6.6 (3 to 26) | 8.9 ± 6.9 (3 to 25) | 0.481 |
SBP (mmHg) | 137.4 ± 21.1 | 132.9 ± 19.6 | 0.367 | 144.7 ± 19.5 | 131.1 ± 20.6 | 0.037 |
DBP (mmHg) | 90.9 ± 15.9 | 86.6 ± 15.3 | 0.215 | 88.5 ± 14.9 | 92.9 ± 16.8 | 0.299 |
BMI (kg/m2) | 24.2 ± 1.3 | 23.2 ± 1.1 | 0.77 | 23.9 ± 1.1 | 24.81.9 | 0.383 |
Smoking | Â | Â | Â | Â | Â | Â |
   Former smokers | 5 (10%) | 5 (13.1) | 0.7401 | 2 (8.6) | 3 (11.1) | 1.0 |
   Nonsmokers | 45 (90%) | 33 (86.8%) | 0.7401 | 21 (91.3) | 24 (88.8) | 1.0 |
Serum triglyceride (mmol/l) | 1.611 ± 0.76 | 1.6 ± 0.79 | 0.755 | 1.5 ± 0.82 | 1.72 ± 0.70 | 0.3367 |
Total cholesterol (mmol/l) | 5.94 ± 1.18 | 5.47 ± 1.03 | 0.047 | 5.8 ± 1.2 | 6.06 ± 1.13 | 0.108 |
HDL-C (mmol/l) | 1.69 ± 0.5 | 1.68 ± 0.49 | 0.943 | 1.56 ± 0.48 | 1.8 ± 0.5 | 0.22 |
LDL-C (mmol/l) | 3.62 ± 1.15 | 3.23 ± 0.88 | 0.148 | 3.52 ± 1.19 | 3.7 ± 1.12 | 0.333 |
ApoA1 (g/l) | 1.31 ± 0.36 | 1.72 ± 0.47 | <0.001 | 1.27 ± 0.3 | 1.33 ± 0.4 | 0.003 |
ApoB (g/l) | 0.95 ± 0.31 | 0.91 ± 0.13 | 0.693 | 0.98 ± 0.38 | 0.89 ± 0.15 | 0.92 |
Paraoxonase-1 activity | 113.6 ± 70.6 | 187.4 ± 68.3 | <0.001 | 84.32 ± 69.66 | 138.7 ± 62.3 | <0.001 |
hs-CRP (mg/l) | 15.2 ± 9.62 | 1.44 ± 0.99 | <0.001 | 22.1 ± 9.78 | 9.36 ± 3.96 | <0.001 |
ESR (mm/hour) | 20.2 ± 17.8 | 8.3 ± 3.9 | <0.001 | 26.5 ± 17.6 | 14.4 ± 16.2 | 0.014 |